What Lorient Capital does

Lorient Capital is a healthcare-focused lower middle market private equity firm founded in 2015 and headquartered in Miami, FL with a secondary office in Birmingham, MI. The firm invests in founder-led and operator-led healthcare businesses at the $5-25M EBITDA entry point, deploying $25-$100M of equity per platform through majority and control structures across buyouts and Executive Partnership builds. Lorient operates three flagship funds with approximately $2 billion in total AUM, with Fund III closing at $500 million in June 2025 on an oversubscribed basis versus its original $350 million target.

The firm's core proprietary assets are L1OS (the Lorient Operating System) and Morpheus, its proprietary data platform. L1OS is a codified operating framework that establishes shared definitions of success, unified planning and execution cadence, accountability structures, and sequenced integration protocols for distributed healthcare operations. Morpheus consolidates operational, financial, workforce, scheduling, workflow, and sector-specific data into a unified architecture, producing weekly role-specific dashboards for executives, regional leaders, managers, and supervisors. The platform supports optimization and anomaly detection use cases across the portfolio.

Lorient's business model is traditional private equity fund management, deriving revenue from management fees on assets under management and carried interest from portfolio company exits. The firm has completed 20 platform investments and 9 realized exits across healthcare sub-sectors including urgent care (American Family Care, Midwest Express Clinic), primary care (Primor Health, Elite Patient Care, Vitae Health Systems), home health and hospice (PurposeCare, Healthy Living Network, Transitions Care), behavioral health (Behavior Frontiers, Centria Healthcare), dental (Reveal Dental Partners), telehealth (PeterMD), workforce solutions (ShiftKey), payments technology (ClearGage), aesthetics (Manor), orthopedic care (The CORE Institute), veterinary (Vet's Best Friend), and career training (MedCerts). The firm is led by Co-Founders and Managing Partners David Berman and Jordan Broome, supported by an integrated team of approximately 11-50 professionals spanning investing, operations, business development, data science, and talent functions.

Name

Lorient Capital

Legal name

Lorient Capital Management, LLC

Website

https://lorientcap.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Lorient Capital is a healthcare-focused lower middle market private equity firm that partners with founder-led and operator-led healthcare businesses, deploying $25-$100M equity per platform and applying its proprietary L1OS operating system and Morpheus data platform across approximately $2 billion in AUM.

Ownership category

akta.pro rank

Product category

Healthcare Private Equity

NAICS

Portfolio Management and Investment Advice (523940), Other Financial Investment Activities (5239)

SIC

Investment Advice (6282)

akta.pro primary industry

Venture Debt Providers (FSANAAAL)

Keywords

• Healthcare private equity
• Lower middle market investing
• Growth equity investments
• Portfolio operations platform
• Fund management services

Headquarters

HQ city

Birmingham

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Private Equity Fund Management: Lorient operates as a healthcare-focused private equity firm managing three flagship funds. Revenue derived from management fees on assets under management and carried interest from portfolio company exits. Fund III closed at $500 million in total commitments.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Lorient Capital is a healthcare-focused private equity firm that invests $25–$100M of equity per platform in founder-led healthcare businesses with $5–25M EBITDA at entry, taking majority or control positions. The firm supports portfolio companies through its proprietary L1OS operating system and Morpheus data platform to standardize workflows, install leadership rhythms, and provide weekly operational visibility across distributed healthcare operations.

Product overview

Lorient Capital is a private equity firm that offers a unified platform combining L1OS (the Lorient Operating System) and Morpheus, a proprietary data platform. L1OS provides operational discipline through standardized workflows, measurable processes, and traceable decisions, while Morpheus consolidates operational, financial, workforce, scheduling, and sector-specific data into structured dashboards. The platform also includes a portfolio of healthcare services companies across urgent care (American Family Care, Midwest Express Clinic), dental care (Reveal Dental Partners), behavioral health (Behavior Frontiers, Centria Healthcare), home health (PurposeCare, Healthy Living Network, Transitions Care), primary care (Primor Health, Elite Patient Care, Vitae Health Systems), telehealth (PeterMD), workforce solutions (ShiftKey), payments technology (ClearGage), aesthetics (Manor), orthopedic care (The CORE Institute), veterinary care (Vet's Best Friend), and career training (MedCerts).

Differentiator

Problem solved

Functional benefit

Brands

• L1OS: Lorient's proprietary Operating System - a repeatable framework that brings operational discipline to every business they partner with, including shared definitions of success, consistent routines, and dependable ways of working.
• Morpheus

Products and services

• Lorient Healthcare Fund III
• Lorient Healthcare Fund II
• Lorient Healthcare Fund I

Quantifiable outcome

• Sequenced integration enables new business units to achieve standard routines in weeks rather than months compared to initial deployment
• +1 more outcomes

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Scale indicators6 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Huron Capital Partners: Lower middle market private equity firm with operating partner support model and healthcare exposure (David Vermiglio, Lorient's CFO/CCO, previously served as VP of Finance at Huron). Comparable in deal size range and operator-supported approach.
• New Mountain Capital: Growth-oriented private equity firm with a dedicated healthcare franchise spanning services, technology, and pharma. Comparable healthcare specialization and operator-led value creation approach.
• Linden Capital Partners: Healthcare-dedicated middle market private equity firm investing in healthcare services and products. Directly comparable given similar sector focus and lower middle market buyout strategy.
• RoundTable Healthcare Partners: Healthcare-focused private equity firm exclusively investing in the healthcare industry across services, products, and distribution. Closely comparable vertical specialization to Lorient.
• Centre Partners: Lower middle market private equity firm with a healthcare services franchise. Comparable to Lorient in target deal size, healthcare sub-sector orientation, and operator-led value creation.
• Audax Group: Lower middle market private equity firm with significant healthcare services activity, executing buy-and-build strategies. Comparable in size, deal profile ($5-25M EBITDA targets), and multi-site healthcare thesis.
• Welsh, Carson, Anderson & Stowe: One of the most established healthcare-focused private equity firms, investing across healthcare services and technology. Highly comparable to Lorient in vertical specialization and lower middle market orientation, though at materially larger AUM scale.
• Avista Capital Partners: Healthcare-focused middle market private equity firm investing in healthcare services, pharma services, and medical technology. Closely comparable to Lorient in vertical focus and platform approach to healthcare.
• Petra Capital Partners: Healthcare-focused private equity firm targeting lower middle market healthcare services and products companies. Closely comparable to Lorient in deal size and sector focus.

Broad incumbents

• KKR Healthcare Strategic Growth: Large-cap global private equity platform with a dedicated healthcare strategic growth franchise. Comparable in healthcare focus but materially larger scale and broader mandate than Lorient's lower middle market orientation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/lorient-capital

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries20 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments10 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lorient Capital